24
Jan 2026
Microbiome differences distinguish preterm infants with parenteral nutrition-associated cholestasis
Microbiome differences distinguish preterm infants with parenteral nutrition-associated cholestasis
STAY INFORMED!
24
Jan 2026
Colorblindness linked to delayed bladder cancer detection and higher mortality
Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis.
24
Jan 2026
Firefighter protective gear restricts movement and may increase injury risk
When firefighters respond to an emergency, the gear they wear to protect themselves can also create challenges that could jeopardize their performance and safety.
24
Jan 2026
Selective inhibition of cPLA2 shows promise against Alzheimer's-related brain inflammation
A multidisciplinary USC research team has identified new compounds that may target a key driver of brain inflammation linked to Alzheimer's disease. Their research just published in the Nature publication npj Drug Discovery.
Why Us?
Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.